Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
10/14/11 SC 14F1 Statement regarding change in majority of directors pursuant to Rule 14f-1 15
10/14/11 8-K Current report filing 414
10/07/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
08/15/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
05/05/11 4 Statement of changes in beneficial ownership of securities 2
05/04/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
03/02/11 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
21
01/05/11 UPLOAD SEC-generated letter 1
12/15/10 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
22
12/02/10 UPLOAD SEC-generated letter 2